We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-5.4%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$111M
AUM Growth
-$3.2M
Cap. Flow
+$4.3M
Cap. Flow %
3.86%
Top 10 Hldgs %
57.45%
Holding
59
New
25
Increased
8
Reduced
9
Closed
16

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$7.38M
3
BRKR icon
Bruker
BRKR
+$6.46M
4
AVTR icon
Avantor
AVTR
+$4.83M
5
CNMD icon
CONMED
CNMD
+$4.82M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$7.86M
2
CI icon
Cigna
CI
+$5.63M
3
A icon
Agilent Technologies
A
+$5.5M
4
BDX icon
Becton Dickinson
BDX
+$3.53M
5
IQV icon
IQVIA
IQV
+$3.31M

Sector Composition

Rank Sector Weight
1 Healthcare 94.79%
2 Real Estate 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
51
Labcorp
LH
$25.8B
– –
-37,910
Closed -$7.86M
MASI
52
DELISTED
Masimo
MASI
– –
-2,850
Closed -$469K
MDT icon
53
Medtronic
MDT
$110B
– –
-27,181
Closed -$2.39M
QGEN icon
54
Qiagen
QGEN
$8.73B
– –
-59,137
Closed -$2.82M
SPY icon
55
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$821B
– –
-6,100
Closed -$27.1M
TEVA icon
56
CALL
Teva Pharmaceuticals
TEVA
$40.8B
– –
-175,000
Closed -$1.32M
VKTX icon
57
Viking Therapeutics
VKTX
$3.95B
– –
-20,754
Closed -$336K
VTR icon
58
Ventas
VTR
$47.7B
– –
-41,575
Closed -$1.97M
ZTS icon
59
Zoetis
ZTS
$30.4B
– –
-7,643
Closed -$1.32M
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Endurant Capital Management held 59 positions worth $111M, down 2.8% from $115M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Endurant Capital Management deployed $4.3M of net new capital in Q3 2023, opening 25 new positions and adding to 8 existing holdings. Its largest new stake was Thermo Fisher Scientific: 13,849 shares worth $7.01M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 66% a quarter earlier, followed by Real Estate.

On the sell side, the largest reduction was Cigna, an estimated $5.63M trimmed.

  • Endurant Capital Management's largest Q3 2023 buy was Thermo Fisher Scientific: 13,849 shares worth $7.01M.
  • Endurant Capital Management added most to BioMarin Pharmaceuticals in Q3 2023, an estimated $12.1M increase.
  • Endurant Capital Management's biggest Q3 2023 reduction was Cigna, cutting an estimated $5.63M.
  • Endurant Capital Management fully exited Labcorp in Q3 2023, selling an estimated $7.86M.
  • Endurant Capital Management's ten largest holdings make up 57% of its $111M portfolio in Q3 2023.
  • Endurant Capital Management opened 25 new positions and closed 16 in Q3 2023.
  • Endurant Capital Management's portfolio value fell 2.8% quarter-over-quarter to $111M.

Based on Endurant Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.